Axonis Therapeutics

Drug DiscoveryWebsite
Current Valuation
N/A
As of January 1, 2021
Total Funding Raised
$149.6M
Across 1 round
Last Round
Accelerator/Incubator

Amount undisclosed

Last Funding
Jan 2021

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
January 1, 2021Accelerator/IncubatorUndisclosedN/A-
Valuation Analysis

Current Valuation Metrics

Axonis Therapeutics is currently valued at N/A as of January 1, 2021. The company has raised a total of $149.6M in funding across 1 funding round.

Track Axonis Therapeutics Valuation Updates

Get notified when Axonis Therapeutics raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Axonis Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Axonis Therapeutics Worth in 2026?

Axonis Therapeutics is a leading private company in the Drug Discovery sector. Track Axonis Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Axonis Therapeutics Valuation is Determined

Private company valuations like Axonis Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.